Edition:
United Kingdom

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

3.45USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$3.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
214,122
52-wk High
$4.53
52-wk Low
$1.20

Latest Key Developments (Source: Significant Developments)

Silence Therapeutics Cuts Stake In Arrowhead Pharma To 3.7 Pct From 6.4 Pct
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Arrowhead Pharmaceuticals Inc ::SILENCE THERAPEUTICS PLC CUTS STAKE IN ARROWHEAD PHARMACEUTICALS TO 3.7 PERCENT AS OF DECEMBER 8 FROM A STAKE OF 6.4 PERCENT AS OF NOVEMBER 29 - SEC FILING.  Full Article

Silence Therapeutics Plc Reports 6.4 Pct Stake In Arrowhead Pharmaceuticals As Of Nov 29
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Arrowhead Pharmaceuticals Inc ::SILENCE THERAPEUTICS PLC REPORTS 6.4 PERCENT STAKE IN ARROWHEAD PHARMACEUTICALS INC AS OF NOVEMBER 29 - SEC FILING.SILENCE THERAPEUTICS SAYS ACQUIRED ARROWHEAD PHARMACEUTICALS' COMMON STOCK IN ORDER TO FACILITATE DISCUSSIONS REGARDING POSSIBLE TRANSACTION WITH THEM.  Full Article

Arrowhead Pharmaceuticals files for mixed shelf of up to $200 mln - SEC filing
Friday, 28 Oct 2016 

Arrowhead Pharmaceuticals Inc :Files for mixed shelf of up to $200 million - SEC filing.  Full Article

Arrowhead Pharma files for sale of aggregate of 3 mln shares of co's common stock by selling shareholder Amgen
Friday, 28 Oct 2016 

Amgen Inc : Arrowhead Pharmaceuticals Inc - Files for sale of aggregate of 3.0 million shares of co's common stock by selling shareholder Amgen Inc - SEC filing .Arrowhead Pharmaceuticals Inc - Co will not receive any proceeds from sale by selling stockholders of shares.  Full Article

Arrowhead Pharmaceuticals announces sale of about 7.6 mln shares
Friday, 2 Sep 2016 

Arrowhead Pharmaceuticals Inc :Sale of an aggregate of 7.6 million shares of common stock, $0.001 par value per share by selling stockholders - sec filing.  Full Article

Arrowhead Pharma qtrly loss $0.32 per share
Tuesday, 9 Aug 2016 

: Arrowhead reports fiscal 2016 third quarter results .Arrowhead pharmaceuticals inc qtrly basic and diluted loss per share $0.32.  Full Article

Arrowhead Pharmaceuticals reports Q2 loss per share $0.35
Tuesday, 10 May 2016 

Arrowhead Pharmaceuticals Inc : Q2 loss per share $0.35 .Q2 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.  Full Article

Arrowhead Research Corp changes name to Arrowhead Pharmaceuticals
Wednesday, 6 Apr 2016 

Arrowhead Research Corp:Has changed its corporate name to Arrowhead Pharmaceuticals Inc.  Full Article

Arrowhead Research Corp's ARC-AAT Granted EMA Orphan Drug Designation
Tuesday, 19 Jan 2016 

Arrowhead Research Corp:Says arrowhead's arc-aat granted ema orphan drug designation.  Full Article